General Updates

August 13, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, “Exchange Plaza”, Corporate Relationship Department, 5th Floor, Plot No. C/1, G Block, 2nd Floor, New Trading Ring, Bandra- Kurla Complex, Bandra (East), Mumbai – P.J. Towers, Dalal Street, 400 051 Mumbai – 400 001 Scrip Name: GLENMARK Scrip Code: 532296 ISIN: INE935A01035 ISIN: INE935A01035 Our Reference No. 49/26-27 Our Reference No. 49/26-27 Dear Sir/ Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulations 30 and 36(1)(b) of the SEBI Listing Regulations, we wish to inform that the letters are being sent by the Company to those Shareholders whose e-mail addresses are not registered with the Company/ Registrar & Transfer Agent/ Depository Participants, providing the web-link and QR Code of Company’s website from where the Integrated Annual Report and Annual General Meeting Notice for FY 2025-26 can be accessed. A copy of the letter is enclosed herewith for your record and the same is also uploaded on the website of the Company at www.glenmarkpharma.com You are requested to take the above information on record. Thanking You Yours Faithfully, For Glenmark Pharmaceuticals Limited Rashmi Khandelwal Company Secretary & Compliance Officer ACS – 28839 Encl: As above Glenmark Pharmaceuticals Limited Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com Glenmark Pharmaceuticals Limited Registered Office: B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026; Corporate Office: Glenmark House, B. D. Sawant Marg, Chakala, Off. Western Express Highway, Andheri (E), Mumbai – 400099. Phone No: +91 22 4018 9999; Fax No.: +91 22 4018 9986; CIN: L24299MH1977PLC019982; Website: www.glenmarkpharma.com; Email: complianceofficer@glenmarkpharma.com NOTICE OF THE 48TH ANNUAL GENERAL MEETING ALONG WITH THE INTEGRATED ANNUAL REPORT Dear Members, AGM We are pleased to inVfoCrm you that the 48th Annual GenerOaAl MVMeeting (“ ”) of Glenmark Pharmaceuticals Limited (“the Company”) is scheduled to bMeC hAeld on Friday, September 11, 2026 at 2.00 P.M. (ISSETB) tIhrough Video Conference (“ ”) / Other Audio-Visual Means (“ ”), in compliance with the various circulars issued by Ministry of Corporate Affairs (“ ”) and Securities and Exchange Board of India (“ ”) from time to time. The Notice of the 4R8TtAh AGM along with the Integrated AnnDuPals Report for the Financial Year 2025-26 is being sent by electronic mode to Members whose e-mail ids are registered with the Company/ Registrar & Share Transfer Agent (“ ”) or the Depository Participants (“ ”). In terms of Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, in the absence of your email id registered with the RTA/ Depository Participant, this letter is being sent to you to provide the web-link and QR Code along with the path to access the Annual Report and Notice of AGM of Company, which is given beloPwa:r ticulars Web-Link QR Code Website Path Notice of AGM https://glenmark.b- https://glenmarkpharma. cdn.net/gpl_pdfs/investors/rep com/annual-report/ FY orts_presentations/AGM%20N 2025-26 AGM Notice OTICE.pdf 2025-26 (Download) Integrated Report for  Financial Year https://glenmark.b- https://glenmarkpharma. 2025-26 cdn.net/gpl_pdfs/investors/rep com/annual-report/ FY orts_presentations/Annual%20 2025-26 Annual Report Report%202025- 2025-26 (Download) 26%20%28Low%20Version%2 9.pdf Members can opt for permanent registration of their e-mail address with their concerned DPs, in respect of shares held in dematerialized form and with RTA in respect of shares held in physical form, by writing to einward.ris@kfintech.com / Complianceofficer@glenmarkpharma.com. We sincerely appreciate your continued support and look forward to your cooperation in embracing our jFoourr nGeleyn tomwaarrkd Ps hgraeramtearc deiugtiitcizaaltsi oLnim anitde dse amless communication. Rashmi Khandelwal CSdo/m- pany Secretary & Compliance Officer Date: August 13, 2026 Place: Mumbai